Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Component (Instruments, Consumables, Software & Services), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarray, In-Situ Hybridization, Others), By Application (Drug Discovery & Development, Cell Biology, Single Cell Analysis, Gene Expression, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region and Competition

April 2023 | 112 pages | ID: T79524D68582EN
TechSci Research

Abstracts

The global transcriptomics market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing application of RNA sequencing and NGS for the diagnosis of genetic illness in developing countries. Additionally, growing initiatives and investments by government organizations for developing new technology, with the introduction of new microarray technology, have significantly increased the demand for transcriptomics across different parts of the globe. Additionally, the rising adoption of new technology and growing demand for personalized medicine for treatments are further expected to increase the demand for transcriptomics, thereby fuelling the market growth through 2028. Furthermore, the increasing number of biopharmaceutical companies and growing expenditure on research and development are further expected to increase the demand for transcriptomics, thereby supporting market growth. Every 4 1/2 minutes, a baby is born with a birth defect in the United States every year, and it affects 1 in every 33 babies born in the United States each year. That translates into about 120,000 babies.

Increasing Demand for Personalized Medicine

Increasing demand for precision medicine & genetic testing and increasing prevalence of conditions such as obesity, hepatitis B, and cancer is expected to boost the market for transcriptomics technology. Additionally, increasing the incidence of genetic mutations related diseases such as down syndrome due to arising in carcinogens and genetic variants among the population is expected to propel the market growth during the forecast period. The increasing prevalence of cancer is expected to offer lucrative growth opportunities for players in the global transcriptomics technologies market. For instance, according to the American Cancer Society, in 2019, total estimated 1,762,450 new cancer cases were diagnosed and 606,880 cancer deaths in the U.S. Particularly, next-generation sequencing (NGS) has transformed the diagnosis of genetic illnesses and allowed medical professionals to offer even more thorough clinical insights. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.

Growing Development of the Healthcare Industry

Due to the increasing technological developments in the research and development sector and the use of RNA sequencing technology in analytical science, the demand for transcriptomics technology is expected to create lucrative growth in the forecast period. Private and government organizations are supporting the research and development sector with the help of pharmaceutical and biotechnology firms which will further boost the market growth in the forecast period. The funding for cancer research has rapidly increased, and most of the government funding centers for breast cancer and childhood cancer. In 2019, the NIH of the US government invested USD460 million in breast cancer which has increased to USD3.5 billion in the year 2022.

Market Segmentation

The global transcriptomics market can be segmented by component, technology, application, end-user, and by region. Based on components, the market can be segmented into Instruments, Consumables, and Software & Services. Based on technology, the market can be differentiated into Next Generation Sequencing, Polymerase Chain Reaction, Microarray, In-Situ Hybridization, and Others. Based on application, the market can be segmented into Drug Discovery & Development, Cell Biology, Single Cell Analysis, Gene Expression, and Others. Based on the end user, the market can be segmented into Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global transcriptomics market on account of the increasing demand for personalized medicine in the country.

Market Players

Agilent Technologies, Inc., ANGLE plc., Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, Fluidigm Corporation, BioSypder, Inc., Danaher Corporation (Cytiva), 10x Genomics, Inc., Pacific Biosciences of California, Inc., NanoString Technologies, Inc. are some of the leading players operating in the Global Transcriptomics Market.

Recent Development

• In May 2022, BioSkryb Genomics first announced the Early Access Program (EAP) for ResolveOME. With this one-cell process, the whole genome and full-length mRNA transcripts of the whole transcriptome can be amplified from a single cell.
• In January 2022, Parse Biosciences, a company that helps researchers with single-cell sequencing, made a deal with Research Instruments Ptv Ltd to sell Parse's Evercore Whole Transcriptome Kits (WTKs), Cell Fixation Kits, and Nuclei Fixation Kits in Singapore and the rest of Southeast Asia.

Report Scope:

In this report, global transcriptomics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

• Transcriptomics Market, By Component:
• Instruments
• Consumables
• Software & Services
• Transcriptomics Market, By Technology:
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray
• In-Situ Hybridization
• Others
• Transcriptomics Market, By Application:
• Drug Discovery & Development
• Cell Biology
• Single Cell Analysis
• Gene Expression
• Others
• Transcriptomics Market, By End User:
• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutions
• Others
• Transcriptomics Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Turkey
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Transcriptomics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. CLINICAL TRIAL ANALYSIS

5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map

6. GLOBAL TRANSCRIPTOMICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Component (Instruments, Consumables, Software & Services)
  6.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarray, In-Situ Hybridization, Others)
  6.2.3. By Application (Drug Discovery & Development, Cell Biology, Single Cell Analysis, Gene Expression, Others)
  6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
  6.2.5. By Region
  6.2.6. By Company (2022)
6.3. Market Map
  6.3.1. By Component
  6.3.2. By Technology
  6.3.3. By Application
  6.3.4. By End User
  6.3.5. By Region

7. NORTH AMERICA TRANSCRIPTOMICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Component
  7.2.2. By Technology
  7.2.3. By Application
  7.2.4. By End User
  7.2.5. By Country
7.3. North America: Country Analysis
  7.3.1. United States Transcriptomics Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Component
      7.3.1.2.2. By Technology
      7.3.1.2.3. By Application
      7.3.1.2.4. By End User
  7.3.2. Canada Transcriptomics Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Component
      7.3.2.2.2. By Technology
      7.3.2.2.3. By Application
      7.3.2.2.4. By End User
  7.3.3. Mexico Transcriptomics Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Component
      7.3.3.2.2. By Technology
      7.3.3.2.3. By Application
      7.3.3.2.4. By End User

8. EUROPE TRANSCRIPTOMICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Component
  8.2.2. By Technology
  8.2.3. By Application
  8.2.4. By End User
  8.2.5. By Country
8.3. Europe: Country Analysis
  8.3.1. France Transcriptomics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Component
      8.3.1.2.2. By Technology
      8.3.1.2.3. By Application
      8.3.1.2.4. By End User
  8.3.2. Germany Transcriptomics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Component
      8.3.2.2.2. By Technology
      8.3.2.2.3. By Application
      8.3.2.2.4. By End User
  8.3.3. United Kingdom Transcriptomics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Component
      8.3.3.2.2. By Technology
      8.3.3.2.3. By Application
      8.3.3.2.4. By End User
  8.3.4. Italy Transcriptomics Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Component
      8.3.4.2.2. By Technology
      8.3.4.2.3. By Application
      8.3.4.2.4. By End User
  8.3.5. Spain Transcriptomics Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Component
      8.3.5.2.2. By Technology
      8.3.5.2.3. By Application
      8.3.5.2.4. By End User

9. ASIA-PACIFIC TRANSCRIPTOMICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Component
  9.2.2. By Technology
  9.2.3. By Application
  9.2.4. By End User
  9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Transcriptomics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Component
      9.3.1.2.2. By Technology
      9.3.1.2.3. By Application
      9.3.1.2.4. By End User
  9.3.2. India Transcriptomics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Component
      9.3.2.2.2. By Technology
      9.3.2.2.3. By Application
      9.3.2.2.4. By End User
  9.3.3. Japan Transcriptomics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Component
      9.3.3.2.2. By Technology
      9.3.3.2.3. By Application
      9.3.3.2.4. By End User
  9.3.4. South Korea Transcriptomics Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Component
      9.3.4.2.2. By Technology
      9.3.4.2.3. By Application
      9.3.4.2.4. By End User
  9.3.5. Australia Transcriptomics Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Component
      9.3.5.2.2. By Technology
      9.3.5.2.3. By Application
      9.3.5.2.4. By End User

10. SOUTH AMERICA TRANSCRIPTOMICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Component
  10.2.2. By Technology
  10.2.3. By Application
  10.2.4. By End User
  10.2.5. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Transcriptomics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Component
      10.3.1.2.2. By Technology
      10.3.1.2.3. By Application
      10.3.1.2.4. By End User
  10.3.2. Argentina Transcriptomics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Component
      10.3.2.2.2. By Technology
      10.3.2.2.3. By Application
      10.3.2.2.4. By End User
  10.3.3. Colombia Transcriptomics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Component
      10.3.3.2.2. By Technology
      10.3.3.2.3. By Application
      10.3.3.2.4. By End User

11. MIDDLE EAST AND AFRICA TRANSCRIPTOMICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Component
  11.2.2. By Technology
  11.2.3. By Application
  11.2.4. By End User
  11.2.5. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Transcriptomics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Component
      11.3.1.2.2. By Technology
      11.3.1.2.3. By Application
      11.3.1.2.4. By End User
  11.3.2. Saudi Arabia Transcriptomics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Component
      11.3.2.2.2. By Technology
      11.3.2.2.3. By Application
      11.3.2.2.4. By End User
  11.3.3. UAE Transcriptomics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Component
      11.3.3.2.2. By Technology
      11.3.3.2.3. By Application
      11.3.3.2.4. By End User
  11.3.4. Turkey Transcriptomics Market Outlook
    11.3.4.1. Market Size & Forecast
      11.3.4.1.1. By Value
    11.3.4.2. Market Share & Forecast
      11.3.4.2.1. By Component
      11.3.4.2.2. By Technology
      11.3.4.2.3. By Application
      11.3.4.2.4. By End User
  11.3.5. Egypt Transcriptomics Market Outlook
    11.3.5.1. Market Size & Forecast
      11.3.5.1.1. By Value
    11.3.5.2. Market Share & Forecast
      11.3.5.2.1. By Component
      11.3.5.2.2. By Technology
      11.3.5.2.3. By Application
      11.3.5.2.4. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches

14. COMPETITIVE LANDSCAPE

14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
  14.6.1. Agilent Technologies, Inc.
  14.6.2. ANGLE plc.
  14.6.3. Bio-Rad Laboratories, Inc.
  14.6.4. Becton, Dickinson, and Company
  14.6.5. Fluidigm Corporation
  14.6.6. BioSypder, Inc.
  14.6.7. Danaher Corporation (Cytiva)
  14.6.8. 10x Genomics, Inc.
  14.6.9. Pacific Biosciences of California, Inc.
  14.6.10. NanoString Technologies, Inc.

15. STRATEGIC RECOMMENDATIONS